These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1974266)

  • 1. Expression of CD15 antigen in urinary bladder transitional cell carcinoma.
    Parham DM; Morton K; Coghill G; Robertson AJ; Kerr MA
    J Clin Pathol; 1990 Jul; 43(7):541-3. PubMed ID: 1974266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
    Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
    Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the tumour-associated antigen CA-242 in transitional cell bladder tumours: a comparison with CA-50.
    Lipponen P; Eskelinen M; Hemmilä I
    Eur J Cancer; 1993; 29A(14):1935-40. PubMed ID: 8280485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SSEA-1 (Lewis(x)) on transitional cell carcinoma of the bladder.
    Konety BR; Ballou B; Jaffe R; Singh J; Reiland J; Hakala TR
    Urol Int; 1997; 58(2):69-74. PubMed ID: 9096265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G; Cavallini A; Piana P; Squintone L; Vottero M; Tizzani A
    Minerva Urol Nefrol; 1992; 44(3):169-72. PubMed ID: 1492266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
    Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
    Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors].
    Kaneko K; Suzuki T; Takasaki E
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1430-5. PubMed ID: 2601216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
    Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
    Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.
    Torenbeek R; Blomjous CE; Quak JJ; Ybema S; Meijer CJ
    J Clin Pathol; 1992 Apr; 45(4):303-7. PubMed ID: 1374431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
    Jones HL; Delahunt B; Bethwaite PB; Thornton A
    Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
    Yamada T; Fukui I; Yokogawa M; Oshima H
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
    [No Abstract]   [Full Text] [Related]  

  • 13. Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma.
    Numahata K; Satoh M; Handa K; Saito S; Ohyama C; Ito A; Takahashi T; Hoshi S; Orikasa S; Hakomori SI
    Cancer; 2002 Feb; 94(3):673-85. PubMed ID: 11857299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial membrane antigen as an immunohistochemical marker for transitional cell carcinoma of the urinary bladder.
    Takashi M; Murase T; Kinjo T; Mitsuya H; Nagura H
    Urol Int; 1987; 42(3):170-5. PubMed ID: 3303592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
    Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
    J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
    Zhang H; Zhao Z; Sun H
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
    Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
    Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ploidy and Tn-antigen expression in the detection of transitional cell neoplasia in non-tumour-bearing patients.
    Pinnock CB; Roxby DJ; Ross JM; Pozza CH; Marshall VR
    Br J Urol; 1995 Apr; 75(4):461-9. PubMed ID: 7788257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
    Kuncová J; Urban M; Mandys V
    APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
    Steffens J; Friedmann W; Lobeck H
    Urol Res; 1985; 13(2):55-9. PubMed ID: 2409654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.